Current diagnosis and treatment of primary aldosteronism

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 11, 2010, Pages 1527-1530

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

adrenal venous sampling; adrenalectomy; eplerenone; plasma renin activity; primary aldosteronism; spironolactone

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; RENIN; SODIUM; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; ESSENTIAL HYPERTENSION; FALSE POSITIVE RESULT; HUMAN; LABORATORY DIAGNOSIS; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; RADIOLOGIST; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM LOAD;

ADRENAL CORTEX; ADRENALECTOMY; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

EID: 78649369211     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.135     Document Type: Article

References (17)

1. Conn JW. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 43, 317 (1955).
2. Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism: a detectable cause of curable 'essential' hypertension. JAMA 193, 200-206 (1965).
3. Kaplan NM, Victor RG. Primary aldosteronism. In: Kaplan's Clinical Hypertension (10th Edition). Lippincot Williams & Wilkins, PA, USA, 339-357 (2010).
4. Gordon RD, Klemm SA, Stowasser M, Tunny TJ, Storie WJ, Rutherford JC. How common is primary aldosteronism? Is it the most frequent cause of curable hypertension? J. Hypertens. Suppl. 11, S310-S311 (1993).
5. Hiramatsu K, YamadaT, Yukimura Y et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch. Intern. Med. 141, 1589-1593 (1981).
6. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 3266-3281 (2008).
7. Mackenzie IS, Brown MJ. Molecular and clinical investigations in patients with low-renin hypertension. Clin. Exp. Nephrol 13, 1-8 (2009).
8. Alvarez-Mendrazo S, Padmanabhan S, Mayosi BM, Watkins H, Avery P, Wallace AM. Familial and phenotypic associations of the aldosterone renin ratio. J. Clin. Endocrinol. Metab. 94, 4324-4333 (2009).
9. Kampers MJE, Lenders JWM, Outheusden L. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann. Intern. Med. 151, 329-337 (2009).
10. Young WF, Stanson AW, What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin. Endocrinol. 70, 14-17 (2009).
11. Stewart PM, Allolio B. Adrenal vein sampling for primary aldosteronism: time for a reality check. Clin. Endocrinol. 72, 146-148 (2010).
12. Catena C, Colussi G, Nadalini E et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168, 80-85 (2008).
13. Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab 95, 2437-2445 (2010).
14. De Souza F, Muxfeldt E, Fiszman R, Salles G. Effcacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 55, 147-152 (2010).
15. Parthasarathy HK, Alhashmi K, McMahon AD et al. Does the ratio of serum aldosterone to plasma renin activity predict the effcacy of diuretics in hypertension? Results of RENALDO. J. Hypertens. 28, 170-177 (2010).
16. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann. Intern. Med. 150, 776-783 (2009).
17. Douma S, Petidis K, Doumas M et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371, 1921-1926 (2008).